Mahmoud M Omar1,2, Nermin E Eleraky3, Amani M El Sisi4, Omiya Ali Hasan1,2. 1. Department of Pharmaceutics and Industrial Pharmacy, Deraya University, El-Minia, Egypt. 2. Department of Pharmaceutics, Sohag University, Sohag, Egypt. 3. Faculty of Pharmacy, Assiut University, Assiut, Arab Republic of Egypt. 4. Department of Pharmaceutics and Industrial Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
Abstract
BACKGROUND: Sumatriptan succinate (SUT) is a potent drug used for relieving or ending migraine and cluster headaches. SUT bioavailability is low (15%) when it is taken orally owing to its gastric breakdown and bloodstream before reaching the target arteries. AIM: The aim of the study was to enhance SUT bioavailability through developing an intranasal transferosomal mucoadhesive gel. METHODS: SUT-loaded nanotransferosomes were prepared by thin film hydration method and characterized for various parameters such as vesicle diameter, percent entrapment efficiency (%EE), in vitro release and ex vivo permeation studies. The in-situ gels were prepared using various ratios of poloxamer 407, poloxamer 188, and carrageenan and characterized for gelation temperature, mucoadhesive strength, and rheological properties. RESULTS: The prepared transferosomes exhibited percent entrapment efficiencies (%EE) of 40.41±3.02 to 77.47±2.85%, mean diameters of 97.25 to 245.01 nm, sustained drug release over 6 hours, and acceptable ex vivo permeation findings. The optimum formulae were incorporated into poloxamer 407 and poloxamer 188-based thermosensitive in-situ gel using carrageenan as a mucoadhesive polymer. Pharmacokinetic evaluation showed that the prepared in-situ gel of SUT-loaded nano-transferosomes gave enhanced bioavailability, 4.09-fold, as compared to oral drug solution. CONCLUSION: Based on enhancing the bioavailability and sustaining the drug release, it can be concluded that the in-situ gel of SUT-loaded nano-transferosomes were developed as a promising non-invasive drug delivery system for treating migraine.
BACKGROUND: Sumatriptan succinate (SUT) is a potent drug used for relieving or ending migraine and cluster headaches. SUT bioavailability is low (15%) when it is taken orally owing to its gastric breakdown and bloodstream before reaching the target arteries. AIM: The aim of the study was to enhance SUT bioavailability through developing an intranasal transferosomal mucoadhesive gel. METHODS: SUT-loaded nanotransferosomes were prepared by thin film hydration method and characterized for various parameters such as vesicle diameter, percent entrapment efficiency (%EE), in vitro release and ex vivo permeation studies. The in-situ gels were prepared using various ratios of poloxamer 407, poloxamer 188, and carrageenan and characterized for gelation temperature, mucoadhesive strength, and rheological properties. RESULTS: The prepared transferosomes exhibited percent entrapment efficiencies (%EE) of 40.41±3.02 to 77.47±2.85%, mean diameters of 97.25 to 245.01 nm, sustained drug release over 6 hours, and acceptable ex vivo permeation findings. The optimum formulae were incorporated into poloxamer 407 and poloxamer 188-based thermosensitive in-situ gel using carrageenan as a mucoadhesive polymer. Pharmacokinetic evaluation showed that the prepared in-situ gel of SUT-loaded nano-transferosomes gave enhanced bioavailability, 4.09-fold, as compared to oral drug solution. CONCLUSION: Based on enhancing the bioavailability and sustaining the drug release, it can be concluded that the in-situ gel of SUT-loaded nano-transferosomes were developed as a promising non-invasive drug delivery system for treating migraine.
Authors: Cristina Balaguer-Fernández; Andres Femenía-Font; Virginia Merino; Damián Córdoba-Díaz; María A Elorza-Barroeta; Alicia López-Castellano; Manuel Córdoba-Díaz Journal: J Liposome Res Date: 2010-04-30 Impact factor: 3.648
Authors: Sheila Villasmil-Sánchez; Wijdane Drhimeur; Sirce Cecilia Salas Ospino; Antonio M Rabasco Alvarez; M L González-Rodríguez Journal: Drug Dev Ind Pharm Date: 2010-06 Impact factor: 3.225
Authors: Osama A A Ahmed; Usama A Fahmy; Shaimaa M Badr-Eldin; Hibah M Aldawsari; Zuhier A Awan; Hani Z Asfour; Ahmed K Kammoun; Giuseppe Caruso; Filippo Caraci; Anas Alfarsi; Raniyah A Al-Ghamdi; Rawan A Al-Ghamdi; Nabil A Alhakamy Journal: Nanomaterials (Basel) Date: 2020-06-29 Impact factor: 5.076
Authors: Mohammed A S Abourehab; Ahmed Khames; Samar Genedy; Shahin Mostafa; Mohammad A Khaleel; Mahmoud M Omar; Amani M El Sisi Journal: Pharmaceutics Date: 2021-04-19 Impact factor: 6.321
Authors: Hadel A Abo El-Enin; Rasha E Mostafa; Marwa F Ahmed; Ibrahim A Naguib; Mohamed A Abdelgawad; Mohammed M Ghoneim; Ebtsam M Abdou Journal: Pharmaceutics Date: 2022-02-14 Impact factor: 6.321